Article
MxA and PKR expression in chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research - 1 Nov 2004
Giannelli Gianluigi, Guadagnino Graziana, Dentico Pietro, Antonelli Guido, Antonaci Salvatore
Abstract excerpt
The effectiveness of therapy for chronic hepatitis C (CHC) patients has greatly improved in the last few years, and the gold standard is currently held to be pegylated interferon (IFN) in combination with ribavirin. Overall, however, the percentage of patients achieving a sustained virologic response (SVR) is only around 50%,and it is not possible to predict those patients who will benefit from therapy. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
